Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Recruiting
Observational Study
Urothelial Carcinoma (UC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Samsung Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single-center, prospective, non-interventional observational cohort study designed to establish a structured recurrence monitoring platform in Korean patients with high-grade non-metastatic upper tract urothelial carcinoma (UTUC).
Eligible adult patients scheduled to receive neoadjuvant chemotherapy followed by radical nephroureterectomy will undergo circulating tumor DNA (ctDNA) sampli…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 19 years
Histologically confirmed high-grade upper tract urothelial carcinoma (renal pelvis and/or ureter)
Clinical stage cT2-T4, cN0-1, M0
Planned neoadjuvant chemotherapy followed by radical nephroureterectomy
ECOG performance status 0-1
Adequate hematologic, hepa…
Contacts